Olaide is a strategic thinker and problem-solver with a 15-year record of successful delivery in public and private sector organisations. With a degree in Sociology, Olaide is fascinated by how people engage with one another, with physical spaces and society in general; and this curiosity drives her.

Olaide leads on external relationships, establishing and nurturing partnerships with key local, business, investor and stakeholder contacts as well as growing the company’s pipeline in new and existing locations across the country.

An experienced public speaker, Olaide is regularly asked to speak and participate in debates on a range of topics including public/private partnership, social impact, arts and culture, broadening engagement and future trends.

In 2022, Olaide was recognised by Estates Gazette as one of the 50 most influential people in the industry.

In 2023, Olaide was recognised as a Woman of Influence by the Planner Magazine.

Gareth Roberts is Head of Development for Science & Technology and Standalone Projects at British Land. British Land has a 10m sq ft net zero development pipeline, over 2m sq ft of which is lab enabled space. Gareth has been at British Land for 10 years and was most recently responsible for the £2.5bn transformation of the Broadgate Campus in the City of London. Gareth is also Chair of the City Property Association, the voice of the real estate industry in the City of London.

A Chartered Surveyor, and Fellow of the Chartered Institute of Marketing, Roz joined Norwich Research Park as Chief Executive Officer of Anglia Innovation Partnership, the science park management company, in May 2022. Roz has had a very successful career managing urban regeneration projects and science parks in Cambridge, Silverstone, Milton Keynes and Bristol. She joined AIP LLP after 15 years with MEPC Ltd – a commercial property company – where she was commercial director. Previous to that she was business development manager at the UK Science Park Association.

Artem founded Mission Street in 2017. Building on extensive track record across investment, development and finance, he has overall strategic responsibility for the growth of the company, project delivery and management.

Prior to Mission Street, Artem was Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BGO), a major international real estate investment and asset management firm (at the time c. £10 Bn under management). He also previously worked for Morgan Stanley in their UK Real Estate team.

Artem’s track record spans development, asset management, real estate private equity and finance. This has included property acquisitions and corporate M&A, leading end-to-end delivery of complex development and asset management projects across the UK, and structuring debt and equity financing (both as the operating partner and capital partner).

Artem graduated with an MA (First Class Honours) in Land Economy at the University of Cambridge and sits on the Investment and Development Committee for the Institute of Cancer Research.

With over 30 years professional experience in Science & Technology, Bio-Medical Life Sciences and Healthcare property delivery, Al is currently Director of Innovation for RAD London in the Royal Albert Docks and leading the development of London’s newest and most exciting Innovation Cluster located near to London City Airport. Al is the former Director of the University of Oxford Science and Innovation Campus and has led and delivered complex laboratory and innovation environments in London, Oxford, Cambridge, the UK regions and Internationally. An experienced strategic operations and development director who has led the successful creation and delivery of multiple business enterprise initiatives, his experience covers a wide range of sectors including enabled laboratory environments for deep tech science and technology, healthcare and wellness, academic and research institutes (bio-medical and life sciences); educational and mixed-use urban planning.

An architect by training, Sally has a reputation for bringing great creativity, innovation and attention to detail to every project she works on, including some of HDR’s most high-profile education, science, workplace, and mixed-use projects around the globe. In her role as Education & Science leader, she directs and executes regional project leadership, strategic planning and business development efforts to help life science corporations and developers achieve their missions and goals.

Angela Kearns is a Corporate Real Estate partner in Clifford Chance's London office specialising in complex development and urban regeneration projects and their funding, direct and indirect investments and HQ occupiers work. Her work spans a broad range of asset classes including life sciences. Angela was shortlisted for Real Estate Individual (London) of the year at the Legal 500 Awards 2020 and is recognised as a Leading Individual by Legal 500 UK.

A Chartered Member of the Royal Institute of British Architects, Mohammed leads HDR’s design studios in Manhattan and Dubai, and heads up HDR’s initiative to incorporate innovation and new technologies into our design process. With over a dozen prestigious design awards, he brings a truly international sensibility to his work, his portfolio clearly illustrating his ability to capture the mission and spirit of a wide variety of organizations and translate these qualities into meaningful architecture. An accomplished ambassador for design, he is a frequent and entertaining guest speaker at industry conferences and forums around the world. Raised in England, Mohammed began his career in London, his first project being a stand-alone dialysis unit in Windsor, and from there has expanded his reach to the US, Europe, the Middle East, and Asia—fusing diverse and innovative design ideas from around the world into his designs.

Michael Walters currently leads Corstorphine & Wright activities in London and the South, managing existing clients, spearheading new business initiatives and expanding the practice's portfolio of work in Lifesciences.

With over 30 years of architectural experience, Michael has fostered enduring partnerships by guiding clients through creative development opportunities across a range of sectors, including commercial, mixed use and R&D. His approach emphasises collaboration, ensuring that each project evolves from concept to completion with meticulous attention to detail.

His career to date has been notably impactful in the pharmaceutical, biopharmaceutical, and R&D sectors. Over a decade of dedicated work on projects for industry giants such as Amgen, GSK, Merck, and Lilly has seen him navigate complex technical requirements, stringent regulatory standards, and demanding timelines. His commitment extends beyond functionality, advocating for spaces that promote communication, collaboration, wellbeing, inclusivity, and sustainability.

At present, Michael is leading several groundbreaking projects for the Pioneer Group. These include the adaptation of Victoria House, a significant Grade II listed building in the Knowledge Quarter for Lifesciences and the transformation of the Grafton Centre, a retail Mall in Cambridge into an innovative life science campus. Alongside the development of Colworth Science Park and Bio City in Nottingham.

Krystal LaBonte is a Director, Scientific Services within AstraZeneca, Cambridge, UK.

Prior to her current role, Krystal was the Facilities Acceptance and Readiness Technical Project

Manager with AstraZeneca, focusing on Operational Readiness and handover of the Discovery

Centre, AstraZeneca’s global research and development headquarters in Cambridge. She played a

key role in operational assurance and enabling science in the DISC, working closely with construction

partners to decrease the operational standup time/startup of science by 18 weeks.

Krystal is a clinical pharmacist and before AstraZeneca, was the Director of Pharmacy and Operations

for the US Air Force’s only hospital in Europe located at RAF Lakenheath, England.

Krystal has a Doctor of Pharmacy degree from the University of Oklahoma and a Masters in

Healthcare Administration from Oklahoma State University with emphasis in change management

and leadership.

Dr Jason Millichamp is the Lead Laboratory & Research Manager for the UCL East Campus, the biggest development in UCL's nearly 200-year history. His role oversees the technical design development and project management of all lab and workshop facilities from concept through to operations. These spaces deliver the technical needs for around 4,000 students and 700 staff, working collaboratively with local communities and businesses. Solving specific interdisciplinary problems by bringing together skillsets from different disciplines to suite social & industrial needs in cutting-edge new centres specialising in ecology, robotics, urbanism, culture, disability, heritage, engineering, technology and health.

Anna Strongman is CEO of Oxford University Development (OUD), a joint

venture between Oxford University and Legal & General set up to build

Innovation Districts and subsidised accommodation for graduate students

and the university workforce.

Anna was previously Managing Partner of Argent LLP in London, where

she spent 12 years executing a range of asset, development, and business

planning projects. Highlights included leading the Asset Management of

King’s Cross, developing Coal Drops Yard, and setting up a BTR portfolio

with JV partners Related. Anna was instrumental in building the business

from 40 people to a team of 200 over a ten-year period and led the

corporate side of the business as Managing Partner.

Before joining Argent, Anna worked in the planning and economic development team of Arup, worked for DTZ

in Scotland, and lived for 18 months in Japan, where she studied Japanese and conducted research at the Japan

Productivity Centre as a Daiwa Scholar.

Ryan leads the technical engineering and operations within the Mace Public & Life Sciences business. A chemical engineer by training, Ryan brings a vast range of knowledge and experiences across the pharma industry, having successfully delivered projects in the manufacturing and R&D space for a variety of clients in the UK and Europe. Whether through design, delivery or commissioning, Ryan has a passion for driving continuous innovation and improvement in the sector. Through exploring new boundaries and technologies for life science facilities, Ryan thrives on uniquely connecting the construction industry with clients, end users, and operations teams to maximise the investment benefit of all stakeholders.

Tim leads the science business area, across the UKIMEA region for Arup. He leads on strategy and

business development, maintains relationships with clients and manages a portfolio of projects.

Tim is a chartered engineer and experienced team leader, having led multi-discipline teams in

delivering engineering solutions on complex highly serviced buildings from concept design phases

through to fully coordinated detail design and construction.

He has been involved in science buildings from his first project over 28 years ago, working on the

design and construction of a facility to produce injectable vaccines. As well as other manufacturing

projects experience, Tim has been involved in the design of many research and development

laboratories for a range of science users and scales of project. These have been for private clients,

government institutes and higher education establishments.

Tim thrives in solving client’s challenges bringing a wealth of experience to provide robust, energy

efficient and sustainable design solutions, applying his knowledge of construction, commissioning

and maintenance.

As head of Mace’s Public Sector & Life Sciences Construction business, Rob has led specialist teams to successfully deliver large-scale, award-winning projects including AstraZeneca’s global R&D Centre in Cambridge, St Bartholomew’s and London Hospitals, and more recently, two lab-enabled buildings on Begbroke Science Park for The University of Oxford and investor L&G. Rob works closely with multidisciplinary project teams and the science community to deliver pioneering facilities that enable clients to compete for the best researchers, scientists, and funding.

Anil Vaidya is the Life Sciences Sector Lead for the West Midlands Growth Company (WMGC), the economic development agency for Birmingham, Coventry, Wolverhampton and some of the surrounding regions. Anil is responsible for supporting international and non-regional UK companies understand the regional opportunities and achieve the West Midlands life science ambitions. Anil has worked in a range of roles within the life science and health sector from private and public consulting in Foreign Direct Investment to founding his own life science companies. Outside of the WMGC, Anil works in a variety of roles as an independent consultant in the sector. Anil holds a MSc in Medical Engineering from Rutgers University/University of Medicine & Dentistry, USA, B.Eng(Hons) in Instrumentation & Control Engineering as well as an MBA from the UK.

Remy is the Commercial Manager at eXmoor Pharma, overseeing business development and commercial engagements across eXmoor’s Consulting, Process Development and GMP business units. Remy has over 15 years’ experience in the Life Sciences sector, and sits on the BioIndustry Association’s Manufacturing Advisory Committee (MAC) and Cell & Gene Therapy Advisory Committee (CGTAC). Remy’s work is focussed on accelerating Cell & Gene Therapy treatments to patients, through delivery of manufacturing expertise to eXmoor’s clients. eXmoor has designed over 45 Clinical and Commercial GMP manufacturing facilities, and has recently opened a 65,000ft2 Cell & Gene Therapy Centre in Bristol, bringing online GMP manufacturing capabilities to support clients.

Remy holds an MBA in Leadership Practice (Open University), PhD in Biochemistry (Bristol) and an MBiol in Molecular & Cellular Biology (Bath).

With a strong background in property and business investment strategies, Mayer is the CEO of Discovery Park and is passionately dedicated to elevating Discovery Park's status as a world-renowned hub for scientific research and innovation. His primary focus extends from nurturing start-ups to facilitating full-scale production, ensuring that Discovery Park is a globally recognised centre of excellence. Mayer's visionary leadership is driven by the goal of creating a vibrant and diverse ecosystem within the park, where partner companies can thrive and access a multitude of resources seamlessly. His commitment to fostering such an environment underscores his belief that collaboration and synergy among the park's inhabitants are key drivers of innovation and progress.

Ellie is an Investment Manager for the UBS AM UK and European Life Sciences funds. The funds focus on the development of fit-for-purpose research and development (R&D) and good manufacturing practice (GMP) facilities across the UK and Europe. Prior to UBS Ellie worked at Jones Lang La Salle (JLL) in the UK Life Sciences team advising clients on strategic Life Sciences development and investment opportunities.

Emily Slupek is a Partner at Bidwells, with a focus on project management of R&D real estate across the

Golden Triangle of Oxford, Cambridge, and London.

She excels in delivering complex projects, with expertise in repurposing commercial spaces, labs,

offices, and mixed-use developments. Currently, she works on projects at the Harwell Campus and with

the University of Oxford.

Emily is a recognized figure in the innovation sector, regularly exploring future market trends with

speaking slots at conferences and roundtables.

Sue leads a dynamic programme of research, working closely with academics and sector

specialists. Much of her work is focused on the real estate implications of the science and

technology sector. This includes the Bidwells Life Science 2030 research programme which

encompasses a study undertaken in conjunction with YouGov investigating the location drivers

of R&D businesses.

Sue’s academic background spans the finance, planning and environmental fields. She started

her career in academia working on planning and urban design publications at the Center for

Urban Policy Research, Rutgers University, USA.

She holds an MSc in Property Investment & Finance from Bayes Business School, an MS in

Planning and Urban Policy from Rutgers University and a BSc in Rural Environment Studies.

Abby leads Oxford’s European office, retail and life sciences businesses,

which have a current AUM of >C$5bn and is accountable for these

businesses’ strategies, capital deployment / acquisitions, strategic asset

management, platform set up, strategic stakeholder relationships and total

returns.

Abby has 14 years of real estate experience across the USA and

Europe. Abby started at Oxford in 2011 and since joining has contributed

to the formulation and execution of Oxford’s investment and asset

management strategies across the UK, Paris and Berlin including developing and maintaining strategic relationships to build Oxford’s profile within these markets / sectors.

Abby sits on Oxford’s European Senior Management Team and is

also sponsoring global strategic initiatives related to its operational model, ESG and digitalization including

how Oxford can better harvest data across its portfolio and markets, all to help drive its performance.

Abby holds a BA magna cum laude in Business Administration from American University in Washington, DC and an MSc with Distinction in Real Estate Economics and Finance from the London School of Economics.

Dominic Williamson is a Managing Director in Brookfield’s Real Estate Group, responsible for all acquisitions of real estate assets, platforms and businesses in the UK and Ireland. Mr. Williamson joined Brookfield in 2017, initially focused on office investments across the UK and Continental Europe before broadening his responsibility to include all real estate sectors within the UK. Prior to joining Brookfield, Mr. Williamson was an investment manager at Gingko Tree Investment, a wholly owned subsidiary of the China State Administration of Foreign Exchange, responsible for acquisition and asset management of real estate throughout Europe. Mr. Williamson is a qualified lawyer and former investment banker, most recently at Morgan Stanley in their European Real Estate Investment Banking team.

Will has over 17 years industry experience in commercial real estate and has spent the past 5 years leading the evolution of the Life Science investment and asset management strategy at Royal London across the mandated funds. During this time RLAM have established a life science portfolio in excess of 1.5 million sq ft principally focussed across the Uk Golden Triangle.

Antara is responsible for the execution of Oxford’s European life sciences strategy. This requires

management and coordination across investment, development, marketing and leasing, financing,

strategic asset management and managing key stakeholder relationships to realise business plans and

deliver returns.

Antara has 16 years of real estate experience having started her career as a development manager

working across the development lifecycle from inception to delivery and stabilisation, across sectors,

clients and project types and sizes. In her 9 years (and counting!) at Oxford, Antara started out on the

development team, playing an instrumental role in development projects across the UK, Paris and Berlin

as well as building out and leading an incredibly talented development team. Antara then took on a new

challenge, overseeing the European residential strategy at Oxford before shifting her focus to life

sciences.

Since 2021, Antara has served as an Independent Committee Member (NED) on the Group Investment

Committee at Hyde Group, one of the largest housing associations in England, a role she took on during

her time on the European residential team at Oxford.

Antara holds a BA (Hons) in Philosophy, Politics and Economics from The University of Oxford and is a

Chartered Surveyor (MRICS).

Antara believes that beaten paths are for beaten people. She is relentlessly curious and optimistic and is

particularly enthusiastic about energising capable teams and channeling expertise, to find creative

solutions to seemingly impossible challenges.

Ben brings 25 years of industry experience to the Firm. As a Managing Director in the Asset Management group, based in London, he manages relationships with operating and development partners and is responsible for the performance of the Firm’s European investments. Prior to joining Harrison Street, Ben was in the Asset Management team at Kennedy Wilson focused on a variety of investments (primarily in UK and Spain) especially hotels, multifamily/PRS, residential development, retail and other specialist property sectors. While at Silverpeak Real Estate (formerly known as Lehman Brothers Real Estate Private Equity) from 2008-2012, he worked across geographies (including Central Europe, France and UK) on a number of developments and joint ventures, and prior to that he worked at Curzon Global Partners in London on Western European acquisitions and asset management (2005-2008). Ben spent two and a half years with ProLogis on their European Fund based in Amsterdam after he started his career at AEW Capital Management in Boston. Ben received a BA in History from Dartmouth College and an MBA from the Kellogg School of Management at Northwestern University.

Jon is a Partner in our London office, specialising in the successful cost management of challenging and complex schemes. He is passionate about using our data and intelligence to achieve each Client’s unique definition of value on every scheme he is involved in.

His recent work at Core Five has included Bankside Yards, a large masterplan scheme for Native Land that encompasses working around significant Network Rail and UKPN assets, and a variety of other projects with Clients including Platform, Sellar, Patrizia, and the Battersea Power Station Development Company.

Prior to joining Core Five Jon worked for Davis Langdon (now AECOM) and was involved in a number of prestigious schemes, including being based at Sellar’s site office on the Shard at London Bridge for four years. He originally graduated from the University of Cambridge, receiving a BA (Hons) and CASM in Mathematics, and subsequently received an MSc in Surveying from the University College of Estate Management.

Jon is part of several initiatives at Core Five dedicated to encouraging diversity in the built environment professions. He was fortunate to join our great industry as a non-cognate himself, and is committed to encouraging access to talent from all backgrounds and creating environments in which they can thrive.

Daniel is currently leading the London Cancer Hub development team, to deliver a sustainable district for excellence in cancer research. The shared vision is to provide a new ecosystem of labs, R&D and commercial facilities, that will attract researchers and scientists from around the world and accelerate the development of groundbreaking cancer treatments.

Daniel is a member of the Royal Institute of British Architects with over 20 years’ experience within the industry. He has worked across all stages of development and specialises in maximising the creation of value through his understanding of design, planning, engineering, financing and construction. Daniel has tutored architectural students at University of East London and has supported the RIBA in the development of their Client Services. He has also mentored emerging architectural practices to develop their business strategies.

Sophie White is the Sector Head for Regeneration at Aviva Capita Partners, with responsibility for

seeking capital investment opportunities in the real estate development sector. She was previously

Director of Infrastructure Funding at Homes England, delivering the agency’s grant and debt funds

for infrastructure alongside new developments. Sophie was at Homes England for 9 years following

14 years in consultancy with Savills, Drivers Jonas and Deloitte Real Estate.

Sophie has experience in the viability and funding of residentially led mixed use schemes with a

specific interest in the Build to Rent sector.

Outside of work Sophie is a board member of the London Bioscience Innovation Centre and will join

the Royal Veterinary College Council as an independent member from August 2024.

Tani, the founder and chief executive of Woodbourne Group, is responsible for leading the

company's operations and management. His role involves shaping the group’s strategic vision,

implementing long-term plans, and overseeing the day-to-day activities of directors. To date, Tani

has effectively acquired, secured planning, developed, and monetised over 1.19 million sq ft of

real estate across all major use-classes. This includes skilfully negotiating intricate financial

arrangements with local planning authorities to successful exits with S&P 500 listed pension

funds and government-funded entities, achieving benchmark returns.

Tani possesses expertise in land assembly, planning, feasibility, risk analysis, and pre leasing of

proposed developments and refurbishments. His ability to engage influencers, originating and

syndicating deals, along with a can-do attitude, seamlessly integrates into the Group's expanding

development pipeline. Recently, he established Woodbourne Ventures, driving diverse

investment deals from Fintech to Cleantech and Web3. The company now strategically focuses

on asset-backed businesses, leveraging its property expertise. Tani has played a crucial role in

steering the company towards a concentration on life sciences and entry into the children's care

market.

Tani is a dedicated advocate for Birmingham, actively supporting the city through philanthropy.

His involvement extends to various international charitable projects, and he participates in local

charity initiatives whenever possible. Tani has been featured in Forbes, Yahoo Finance, and BBC

News and is a regular speaker at global family-office conferences, real estate, and private equity

forums, providing valuable insights into property, finance, and investing.

Mark specialises in delivering innovative engineering solutions in the hospitality sector, blending heritage preservation with modern functionality.

Currently, he leads the prestigious refurbishment of a world-leading 5* hotel in London, balancing historic integrity with cutting-edge engineering on one of the city’s most complex sites. His expertise is in early-stage strategic guidance and complex sequencing on landmark developments.

Manisha Kulkarni is Director of Science & Technology at Bulb, with over 25 years of experience in scientific research and laboratory design across the pharmaceutical, chemical, and construction sectors. She holds a PhD in Organic Chemistry and brings deep expertise in translating complex scientific requirements into high-performing, future-ready laboratory environments. At Bulb, she advises on lab design, workflow optimisation, and regulatory frameworks, helping bridge the gap between science and the built environment.

Paul is a board partner at G&T has provided cost management and project management advice to developers, operators and investors across a wide variety of sectors for over 17 years. His extensive experience and understanding of construction methodology allows him to offer accurate early cost advice and proactively control cost through the design process.

Paul is part of G&T’s life and commercial science sector group and is involved in some of the most significant life science projects across London and the golden triangle.

Hsin Loke joined OMass Therapeutics in July 2018. Previously she spent 16 years at GSK in a variety of leadership roles; most recently leading Finance, Strategy and Operations for the Company’s Rare Diseases Unit, which developed and commercialised a portfolio of innovative medicines, including gene therapies. Prior to this, Hsin led Strategy and Operations for GSK’s biopharm unit, and has held roles within an internal consulting group, commercial finance and internal audit. Hsin qualified as a Chartered Accountant with PwC, and completed her BA (Hons) in Biological Sciences and D.Phil. in genetics and immunology at Oxford University

Dace plays a significant part in increasing investment into the North of England and help the region achieve ambitions aligned to levelling up priorities focussing on the Life Sciences sector.

Dace works closely with overseas businesses, matching them to opportunities and supporting and advising them on setting up or expanding their business in the north. Dace works with both new and existing investors and wins investment by:

•     working closely with regional partners to attract investors to the North

•     matching investors with live opportunities

•     connecting investors with industry contacts

•     identifying suitable investment locations

•     organising regular inward and outward investor delegations for the North

Amy Hockley is the Head of Science and Technology Leasing at British Land, responsible for its innovation campuses and assets, including Regent’s Place in the Knowledge Quarter and the 53-acre campus at Canada Water.

Amy leads on occupier insights in this sector and works closely with the development and asset management teams to ensure the right product and ecosystem are delivered to meet customer needs.

British Land have a pipeline of 2m sq ft of science and technology space capable of being delivered.

Dan Pagella is Senior Director, Asset Management responsible for the co-

ordination and implementation ARC’s Business Plan at Asset level. He brings a

particular passion for creating and managing collaborative, engaging

environments that attract and retain the brightest minds needed to achieve the

commercial and scientific ambitions of ARC’s members. Dan has over 20 years’ experience of delivering complex, varied and constrained

projects with a broad range of stakeholders and interested parties. His

experience ranges from managing the continued delivery of a 20-year

masterplan for the provision of over 4 million square feet of employment space

alongside education, housing, healthcare, and retail facilities, to the creation of

serviced office and incubator laboratory concepts for Arlington and ARC

respectively.

Liz is a Chartered Architect, Partner, and Science Sector lead at Ridge, with over 20 years’ experience in the delivery of complex, multi-stakeholder, technical and mixed-use developments. A visionary design lead, Liz is focused on delivering masterplan designs for R&D campuses across the UK. Working closely with life science estate managers and end-users, Liz heads up a team that designs safe, sustainable, functional, and adaptable spaces supporting the pursuit of progress. Her approach combines practical architectural skills with an understanding of the technical and complex social requirements of science-focused facilities. Recent projects include the UK Atomic Energy Authority (UKAEA) and Harwell Campus.

Graham is one of the partners in the Hogan Lovells UK Real Estate team and coordinates the firm’s Life Sciences Real Estate sector. Graham has a long track record with Life Sciences, acting for both investors and operators. Graham was part of the team that set up the original Harwell Science and Innovation Campus for the UKAEA, a public and private joint venture that delivered the campus we see thriving today. Since then, Graham has acted for a range of Life Science operators, including Eli Lilly on all of Lilly’s UK Real Estate lab, office and development requirements. Graham regularly contributes to Real Estate Life Sciences thought leadership, as part of which he delivers training to clients considering: ground-up developments, repurposing existing assets for Life Sciences use, flexible leasing models, cooperation and promotion agreements, ESG’s role in Life Sciences, as well as bespoke asset management and dilapidations strategies. Graham takes a commercial but collaborative approach to negotiations, as it is imperative that parties approaching a Life Sciences Real Estate deal do so with a true sense of flexibility, partnership and innovation.